- Home
- AKRO vs GRBK Comparison
AKRO vs GRBK Comparison
Compare AKRO & GRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- GRBK
- Stock Information
- Founded
- AKRO 2017
- GRBK N/A
- Country
- AKRO United States
- GRBK United States
- Employees
- AKRO N/A
- GRBK N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- GRBK Homebuilding
- Sector
- AKRO Health Care
- GRBK Consumer Discretionary
- Exchange
- AKRO Nasdaq
- GRBK Nasdaq
- Market Cap
- AKRO 3.7B
- GRBK 3.4B
- IPO Year
- AKRO 2019
- GRBK N/A
- Fundamental
- Price
- AKRO $46.50
- GRBK N/A
- Analyst Decision
- AKRO Strong Buy
- GRBK Buy
- Analyst Count
- AKRO 8
- GRBK 2
- Target Price
- AKRO $80.38
- GRBK $71.00
- AVG Volume (30 Days)
- AKRO 1.2M
- GRBK 255.6K
- Earning Date
- AKRO 11-07-2025
- GRBK 10-29-2025
- Dividend Yield
- AKRO N/A
- GRBK N/A
- EPS Growth
- AKRO N/A
- GRBK 7.68
- EPS
- AKRO N/A
- GRBK 7.83
- Revenue
- AKRO N/A
- GRBK $2,137,742,000.00
- Revenue This Year
- AKRO N/A
- GRBK N/A
- Revenue Next Year
- AKRO N/A
- GRBK $6.60
- P/E Ratio
- AKRO N/A
- GRBK $8.82
- Revenue Growth
- AKRO N/A
- GRBK 13.87
- 52 Week Low
- AKRO $21.34
- GRBK $50.57
- 52 Week High
- AKRO $58.40
- GRBK $84.66
- Technical
- Relative Strength Index (RSI)
- AKRO 47.87
- GRBK 45.31
- Support Level
- AKRO $45.20
- GRBK $69.98
- Resistance Level
- AKRO $47.40
- GRBK $77.93
- Average True Range (ATR)
- AKRO 1.46
- GRBK 1.87
- MACD
- AKRO 0.06
- GRBK -0.37
- Stochastic Oscillator
- AKRO 34.90
- GRBK 9.01
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About GRBK Green Brick Partners Inc.
Green Brick Partners Inc is a homebuilding and land development company. It acquires and develops land, as well as provides land and construction financing to its controlled builders. The company has three reportable segments: builder operations central, builder operations southeast, and land development. The majority of the company's revenue is generated from the builder operations central segment which is entirely the operations of builders in Texas. The company is engaged in various aspects of the homebuilding process, including land acquisition and development, entitlements, design, construction, marketing, sales, and brand image creation. In addition to homebuilding, the company provides home financing services, such as mortgage and title.